Only Jinsan Biotechnology has completed a Pre-A+ round financing of tens of millions of yuan
36Kr learned that Tuoxin Pharmaceutical, a company listed on the Shenzhen Stock Exchange, announced a strategic investment of tens of millions of yuan in Jiangsu Jinsan Biotechnology and signed a cooperation agreement. This comes just three months after Jiangsu Jinsan completed its 100 million yuan Pre-A round of financing, demonstrating the capital market's continued optimism towards the industrialization of anti-aging raw material ergot sulfur